| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |